Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Thomas Brown, M.D.

Concepts (116)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteoarthritis, Hip1620234122.650 Why?
Osteoarthritis, Knee20202312222.540 Why?
Nerve Growth Factor620231492.310 Why?
Analgesics13202210401.540 Why?
Paresthesia620231611.240 Why?
Isoxazoles620082160.730 Why?
Pain10202349880.670 Why?
Double-Blind Method262023120250.590 Why?
Low Back Pain520219560.580 Why?
Pain Measurement18202334200.580 Why?
Arthralgia420194560.560 Why?
Arthroplasty, Replacement520223390.520 Why?
Anti-Inflammatory Agents, Non-Steroidal11202322820.500 Why?
Naproxen52021990.460 Why?
Cyclooxygenase Inhibitors220053710.440 Why?
Receptor, Nerve Growth Factor22013480.410 Why?
Sulfonamides5201419400.390 Why?
Bone Neoplasms2202325300.320 Why?
Analgesics, Non-Narcotic120113660.310 Why?
Antibodies, Monoclonal2201892740.300 Why?
Hypesthesia320231090.290 Why?
Treatment Outcome272023631070.280 Why?
Molecular Targeted Therapy1201827250.280 Why?
Dose-Response Relationship, Drug112022109430.230 Why?
Clinical Trials, Phase III as Topic220238410.210 Why?
Osteoarthritis2202210360.210 Why?
Oxycodone220141530.210 Why?
Narcotics220143430.200 Why?
Peripheral Nerves120234660.180 Why?
Injections, Subcutaneous420216670.160 Why?
Injections, Intravenous2201114200.160 Why?
Diclofenac22021710.160 Why?
Hallux Valgus22008650.150 Why?
Neurilemmoma120225470.140 Why?
Cyclooxygenase 2 Inhibitors220083200.140 Why?
Drug Administration Schedule6201949330.130 Why?
Aged2020211632880.120 Why?
Signal Transduction12018234040.120 Why?
Pain, Postoperative3200816430.110 Why?
Middle Aged2220212133900.110 Why?
Humans4020237443660.110 Why?
Migraine Disorders1200516200.110 Why?
Neural Conduction120144400.110 Why?
Aged, 80 and over112021577760.110 Why?
Randomized Controlled Trials as Topic3202399550.100 Why?
Adult2020222140520.100 Why?
Severity of Illness Index62017155350.100 Why?
Nerve Fibers120146870.090 Why?
Electrocardiography2201564420.090 Why?
Male2320213501150.090 Why?
Female2320213801930.080 Why?
Neuralgia120155700.080 Why?
Follow-Up Studies52020390520.080 Why?
Range of Motion, Articular1201415780.080 Why?
Osteonecrosis220212270.080 Why?
Headache2201512260.070 Why?
Analysis of Variance1201563660.070 Why?
Radiography1201770230.070 Why?
Arthroplasty, Replacement, Hip2202014620.060 Why?
Pyrazoles1201419720.060 Why?
Walking1201011800.060 Why?
Heart Rate1201440920.060 Why?
Respiratory Tract Infections120109610.060 Why?
Clinical Trials as Topic1201779140.050 Why?
Antibodies, Blocking120212530.050 Why?
Intra-Articular Fractures12021680.050 Why?
Morpholines120045710.050 Why?
Fractures, Spontaneous120212300.040 Why?
Disease Progression32021132860.040 Why?
Canada1200420650.040 Why?
Blood Pressure1201485510.040 Why?
Neurofibromatoses120222990.040 Why?
Japan1202113600.040 Why?
Infusions, Intravenous2201422740.040 Why?
Ontario120143830.030 Why?
Adrenal Cortex Hormones1202218560.030 Why?
Reference Standards1201710250.030 Why?
Drug Therapy, Combination2201464890.030 Why?
Young Adult32014564290.030 Why?
Time Factors12014400750.030 Why?
Dizziness120152510.030 Why?
Antidepressive Agents1200428380.030 Why?
Knee Joint1202016800.020 Why?
Observer Variation1201725930.020 Why?
Depressive Disorder1200437470.020 Why?
Adolescent52014857790.020 Why?
Arthritis, Rheumatoid1200637120.020 Why?
Edema120147890.020 Why?
Delayed-Action Preparations120139680.020 Why?
Fractures, Bone1202119470.020 Why?
Placebo Effect120135020.020 Why?
Arthroplasty, Replacement, Knee1202014580.020 Why?
Prospective Studies22021532900.020 Why?
Animals220181687680.020 Why?
Administration, Oral1201439140.020 Why?
Analgesics, Opioid1202236770.020 Why?
Patient Selection1201742160.020 Why?
Incidence12022209520.010 Why?
Receptors, Adrenergic120041550.010 Why?
Controlled Clinical Trials as Topic120041870.010 Why?
Skin Neoplasms1202256920.010 Why?
Adrenergic Uptake Inhibitors120041890.010 Why?
Drug Tolerance120043760.010 Why?
Time120045420.010 Why?
United States22013698720.010 Why?
Norepinephrine120049090.010 Why?
Quality of Life12022128020.010 Why?
Cohort Studies12022405590.010 Why?
Serotonin1200410170.010 Why?
Reproducibility of Results12017199050.010 Why?
Prevalence12013152210.010 Why?
Patient Satisfaction1200833950.010 Why?
Retrospective Studies12022774600.010 Why?
Risk Assessment12014233360.010 Why?
Cognition1200467700.000 Why?
Risk Factors12013722960.000 Why?
Brown's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (116)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.